Arrowhead Pharmaceuticals Inc (ARWR)
Financial leverage ratio
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 1,385,300 | 1,380,610 | 1,573,500 | 1,013,690 | 1,139,800 | 883,759 | 955,150 | 626,286 | 765,552 | 795,856 | 891,308 | 891,489 | 691,939 | 751,782 | 703,575 | 638,539 | 710,148 | 734,927 | 756,795 | 499,251 |
| Total stockholders’ equity | US$ in thousands | 466,052 | 519,806 | 683,321 | 52,589 | 185,444 | 330,547 | 483,794 | 160,407 | 271,343 | 364,830 | 446,772 | 377,039 | 105,960 | 453,927 | 452,266 | 372,560 | 408,822 | 436,890 | 445,549 | 454,472 |
| Financial leverage ratio | 2.97 | 2.66 | 2.30 | 19.28 | 6.15 | 2.67 | 1.97 | 3.90 | 2.82 | 2.18 | 1.99 | 2.36 | 6.53 | 1.66 | 1.56 | 1.71 | 1.74 | 1.68 | 1.70 | 1.10 |
September 30, 2025 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,385,300K ÷ $466,052K
= 2.97